US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cognition Therapeutics, Inc

0.6674

+0.081613.93%

Post-market: 0.67150.0041+0.61%19:59 EDT

Volume:4.09M

Turnover:2.65M

Market Cap:41.37M

PE:-0.93

High:0.6996

Open:0.5555

Low:0.5555

Close:0.5858

Loading ...

Overview Company News Filings

Cognition Therapeutics’ Expanded Access Program for CT1812: A Promising Update for Investors

Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease

Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesine’s Protection of Neurons and Synapses in Alzheimer’s Disease

Cognition Therapeutics ot present data from zervimesine Phase 2 study

Cognition Therapeutics' Positive Clinical Data from Zervimesine (CT1812) Phase 2 Study in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at AAIC

Cognition completes End-of-Phase 2 meeting with FDA for zervimesine

Cognition Therapeutics Completes End-of-Phase 2 Meeting with FDA for Zervimesine (CT1812) in Alzheimer’s Disease

Cognition Therapeutics’ Promising Clinical Progress and Regulatory Advancements Justify Buy Rating

Cognition Therapeutics announces Phase 2 ‘START’ study surpassed 50% enrollment

BRIEF-Cognition Therapeutics Study Of Zervimesine (CT1812) In Early Alzheimer’s Disease Surpasses 50% Enrollment Target

Cognition Therapeutics Advances with CT1812 in Dementia Study

Cognition Therapeutics Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

BRIEF-Cognition Therapeutics Provides Regulatory Update On Zervimesine In Alzheimer’s Disease

Cognition Therapeutics Inc. Conducted Annual Stockholders Meeting Virtually

Cognition Therapeutics Launches Expanded Access Program for Zervimesine

Cognition Therapeutics Advances to Phase 3 Trials

Cognition Therapeutics price target lowered to $3 from $5 at H.C. Wainwright

Cognition Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Press Release: Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update

Cognition Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CGTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGTX\",,,,,undefined,":{"symbol":"CGTX","market":"US","secType":"STK","nameCN":"Cognition Therapeutics, Inc","latestPrice":0.6674,"timestamp":1754078400000,"preClose":0.5858,"halted":0,"volume":4092719,"hourTrading":{"tag":"盘后","latestPrice":0.6715,"preClose":0.6674,"latestTime":"19:59 EDT","volume":68438,"amount":46491.397151,"timestamp":1754092784207},"delay":0,"floatShares":55612659,"shares":61993046,"eps":-0.721131,"marketStatus":"Market Closed","change":0.0816,"latestTime":"08-01 16:00:00 EDT","open":0.5555,"high":0.6996,"low":0.5555,"amount":2645673.9418617003,"amplitude":0.245988,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.721131,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":0.5858,"preHourTrading":{"tag":"盘前","latestPrice":0.5642,"preClose":0.5858,"latestTime":"09:29 EDT","volume":43598,"amount":25882.16763814,"timestamp":1754054998789},"postHourTrading":{"tag":"盘后","latestPrice":0.6715,"preClose":0.6674,"latestTime":"19:59 EDT","volume":68438,"amount":46491.397151,"timestamp":1754092784207},"volumeRatio":0.8895824374917792},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGTX\",,,,,undefined,":{"symbol":"CGTX","floatShares":55612659,"roa":"-107.53%","roe":"-161.93%","lyrEps":-0.855043,"volumeRatio":0.8895824374917792,"shares":61993046,"dividePrice":0,"high":0.6996,"amplitude":0.245988,"preClose":0.5858,"low":0.5555,"week52Low":0.222301,"pbRate":"3.37","week52High":1.29,"institutionHeld":0,"latestPrice":0.6674,"eps":-0.721131,"divideRate":0,"volume":4092719,"delay":0,"ttmEps":-0.721131,"open":0.5555,"prevYearClose":0.7013,"prevWeekClose":0.84,"prevMonthClose":0.5858,"prevQuarterClose":0.3098,"fiveDayClose":0.84,"twentyDayClose":0.405,"sixtyDayClose":0.4175},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556810338","title":"Cognition Therapeutics’ Expanded Access Program for CT1812: A Promising Update for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2556810338","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556810338?lang=en_us&edition=fundamental","pubTime":"2025-08-02 00:17","pubTimestamp":1754065028,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics, Inc. (($CGTX)) announced an update on their ongoing clinical study. The recent clinical study update from Cognition Therape...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-expanded-access-program-for-ct1812-a-promising-update-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-expanded-access-program-for-ct1812-a-promising-update-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","ISBC","BK4211","CGTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2555056899","title":"Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2555056899","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555056899?lang=en_us&edition=fundamental","pubTime":"2025-07-29 19:30","pubTimestamp":1753788600,"startTime":"0","endTime":"0","summary":"- Zervimesine’s impact on debilitating DLB behavioral symptoms highlighted in podium presentation -- Plasma p-tau217 levels can identify Alzheimer’s patients most likely to benefit from zervimesine tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/29/3123138/0/en/Cognition-Therapeutics-Presents-Data-at-AAIC-Highlighting-Broad-Neurological-Impact-of-Zervimesine-CT1812-in-Dementia-with-Lewy-Bodies-and-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CAF","CGTX","BK4110","BK4139","BK4539","LU0240878834.USD","LU0205193047.USD","CDR","CSF","LU0205194284.USD","LU0240877869.USD","BK4097","DLB","LU0348723411.USD","AAIC","BK4007","LU0345774391.USD","BK4080","LU0345774631.USD"],"gpt_icon":0},{"id":"2553797084","title":"Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesine’s Protection of Neurons and Synapses in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2553797084","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553797084?lang=en_us&edition=fundamental","pubTime":"2025-07-21 19:30","pubTimestamp":1753097400,"startTime":"0","endTime":"0","summary":"In Vitro Experiments Showing Protection of Neurons under Disease Conditions Support Proteomics Biomarker Analysis from Phase 2 SEQUEL StudyPITTSBURGH, July  21, 2025  (GLOBE NEWSWIRE) -- Cognition The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/21/3118639/0/en/Cognition-Therapeutics-Publishes-Proteomic-Analysis-Elucidating-Zervimesine-s-Protection-of-Neurons-and-Synapses-in-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240878834.USD","LU0240877869.USD","BK4097","LU0205194284.USD","CGTX","LU0345774391.USD","BK4539","LU0205193047.USD","LENZ","LU0348723411.USD","DLB","BK4139","LU0345774631.USD","BK4007"],"gpt_icon":0},{"id":"2551140507","title":"Cognition Therapeutics ot present data from zervimesine Phase 2 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2551140507","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551140507?lang=en_us&edition=fundamental","pubTime":"2025-07-16 19:36","pubTimestamp":1752665782,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) announced that James Galvin, MD, MPH will present results from the Phase 2 ‘SHIMMER’ study of zervimesine in dementia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-ot-present-data-from-zervimesine-phase-2-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-ot-present-data-from-zervimesine-phase-2-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","CGTX","BK4539","BK4139"],"gpt_icon":0},{"id":"2551363140","title":"Cognition Therapeutics' Positive Clinical Data from Zervimesine (CT1812) Phase 2 Study in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at AAIC","url":"https://stock-news.laohu8.com/highlight/detail?id=2551363140","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551363140?lang=en_us&edition=fundamental","pubTime":"2025-07-16 19:30","pubTimestamp":1752665400,"startTime":"0","endTime":"0","summary":"- Zervimesine-treated participants tested 86% better on behavioral outcomes (NPI 12), 52% on activities of daily living, 91% on cognitive fluctuations, and 62% on motor symptoms as compared to placebo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/16/3116291/0/en/Cognition-Therapeutics-Positive-Clinical-Data-from-Zervimesine-CT1812-Phase-2-Study-in-Dementia-with-Lewy-Bodies-DLB-will-be-Presented-in-a-Podium-Presentation-at-AAIC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240878834.USD","CAF","AAIC","LU0240877869.USD","BK4007","CDR","LU0205193047.USD","BK4110","BK4539","BK4097","BK4139","DLB","CGTX","LU0205194284.USD","LENZ","LU0348723411.USD","BK4080","LU0345774391.USD","LU0345774631.USD"],"gpt_icon":0},{"id":"2550899647","title":"Cognition completes End-of-Phase 2 meeting with FDA for zervimesine","url":"https://stock-news.laohu8.com/highlight/detail?id=2550899647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550899647?lang=en_us&edition=fundamental","pubTime":"2025-07-10 19:35","pubTimestamp":1752147357,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) conducted an end-of-Phase 2 meeting with the U.S. Food and Drug Administration on July 9, 2025. The objective of this...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-completes-end-of-phase-2-meeting-with-fda-for-zervimesine-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-completes-end-of-phase-2-meeting-with-fda-for-zervimesine-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CGTX"],"gpt_icon":0},{"id":"2550642476","title":"Cognition Therapeutics Completes End-of-Phase 2 Meeting with FDA for Zervimesine (CT1812) in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2550642476","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550642476?lang=en_us&edition=fundamental","pubTime":"2025-07-10 19:30","pubTimestamp":1752147000,"startTime":"0","endTime":"0","summary":"Positive Discussion on Path Forward for Registrational ProgramPURCHASE, N.Y., July  10, 2025  (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical st","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/10/3113149/0/en/Cognition-Therapeutics-Completes-End-of-Phase-2-Meeting-with-FDA-for-Zervimesine-CT1812-in-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007","BK4539","LENZ","LU0240877869.USD","BK4139","LU0345774631.USD","LU0348723411.USD","LU0205193047.USD","DLB","LU0205194284.USD","LU0345774391.USD","LU0240878834.USD","BK4097"],"gpt_icon":0},{"id":"2548480349","title":"Cognition Therapeutics’ Promising Clinical Progress and Regulatory Advancements Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2548480349","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548480349?lang=en_us&edition=fundamental","pubTime":"2025-07-03 18:16","pubTimestamp":1751537814,"startTime":"0","endTime":"0","summary":"Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Cognition Therapeutics and keeping the price target at $3.00. Ram Selvaraju h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cognition-therapeutics-promising-clinical-progress-and-regulatory-advancements-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cognition-therapeutics-promising-clinical-progress-and-regulatory-advancements-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","PRGS","LENZ"],"gpt_icon":0},{"id":"2548005067","title":"Cognition Therapeutics announces Phase 2 ‘START’ study surpassed 50% enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2548005067","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548005067?lang=en_us&edition=fundamental","pubTime":"2025-07-01 19:35","pubTimestamp":1751369731,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) announced that the Phase 2 ‘START’ Study surpasses 50% enrollment. The START Study is being conducted with partners a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-announces-phase-2-start-study-surpassed-50-enrollment-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-announces-phase-2-start-study-surpassed-50-enrollment-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2548179005","title":"BRIEF-Cognition Therapeutics Study Of Zervimesine (CT1812) In Early Alzheimer’s Disease Surpasses 50% Enrollment Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2548179005","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548179005?lang=en_us&edition=fundamental","pubTime":"2025-07-01 19:32","pubTimestamp":1751369578,"startTime":"0","endTime":"0","summary":"BRIEF-Cognition Therapeutics Study Of Zervimesine (CT1812) In Early Alzheimer’s Disease Surpasses 50% Enrollment TargetJuly 1 (Reuters) - Cognition Therapeutics Inc CGTX.O:COGNITION THERAPEUTICS STUDY","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA3PW7HY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"gpt_icon":0},{"id":"2548401673","title":"Cognition Therapeutics Advances with CT1812 in Dementia Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2548401673","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548401673?lang=en_us&edition=fundamental","pubTime":"2025-07-01 00:00","pubTimestamp":1751299248,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics, Inc. (($CGTX)) announced an update on their ongoing clinical study. Study Overview: Cognition Therapeutics, Inc. has initia...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-advances-with-ct1812-in-dementia-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-advances-with-ct1812-in-dementia-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CGTX","BK4539","LENZ","BK4007"],"gpt_icon":0},{"id":"2546872797","title":"Cognition Therapeutics Price Target Maintained With a $3.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2546872797","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546872797?lang=en_us&edition=fundamental","pubTime":"2025-06-26 19:48","pubTimestamp":1750938480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 26, 2025 07:48 ET (11:48 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CGTX"],"gpt_icon":0},{"id":"2546126282","title":"BRIEF-Cognition Therapeutics Provides Regulatory Update On Zervimesine In Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2546126282","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546126282?lang=en_us&edition=fundamental","pubTime":"2025-06-25 19:34","pubTimestamp":1750851244,"startTime":"0","endTime":"0","summary":"BRIEF-Cognition Therapeutics Provides Regulatory Update On Zervimesine In Alzheimer’s DiseaseJune 25 (Reuters) - Cognition Therapeutics Inc CGTX.O:COGNITION THERAPEUTICS PROVIDES REGULATORY UPDATE ON ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nTUA9QDPFT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CGTX"],"gpt_icon":0},{"id":"2545950170","title":"Cognition Therapeutics Inc. Conducted Annual Stockholders Meeting Virtually","url":"https://stock-news.laohu8.com/highlight/detail?id=2545950170","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545950170?lang=en_us&edition=fundamental","pubTime":"2025-06-21 04:02","pubTimestamp":1750449734,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics Inc. conducted its Annual Meeting of Stockholders virtually on June 18, 2025. Peggy Wallace and Ellen B. Richstone were elected to the Board of Directors as Class I directors. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for the 2025 fiscal year was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cognition Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL3VJpmh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007"],"gpt_icon":0},{"id":"2540572779","title":"Cognition Therapeutics Launches Expanded Access Program for Zervimesine","url":"https://stock-news.laohu8.com/highlight/detail?id=2540572779","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540572779?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:57","pubTimestamp":1748951873,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics ( ($CGTX) ) just unveiled an announcement. On June 3, 2025, Cognition Therapeutics announced the launch of an expanded acces...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-launches-expanded-access-program-for-zervimesine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-launches-expanded-access-program-for-zervimesine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","CGTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2540762538","title":"Cognition Therapeutics Advances to Phase 3 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2540762538","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540762538?lang=en_us&edition=fundamental","pubTime":"2025-06-02 18:36","pubTimestamp":1748860607,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics ( ($CGTX) ) just unveiled an announcement. Cognition Therapeutics has presented compelling data supporting the efficacy and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-advances-to-phase-3-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-advances-to-phase-3-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","CGTX","BK4539","BK4007"],"gpt_icon":0},{"id":"2538450863","title":"Cognition Therapeutics price target lowered to $3 from $5 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2538450863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538450863?lang=en_us&edition=fundamental","pubTime":"2025-05-27 18:15","pubTimestamp":1748340921,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Cognition Therapeutics (CGTX) to $3 from $5 and keeps a Buy rating on...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-price-target-lowered-to-3-from-5-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-price-target-lowered-to-3-from-5-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","LENZ"],"gpt_icon":0},{"id":"2533356969","title":"Cognition Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533356969","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533356969?lang=en_us&edition=fundamental","pubTime":"2025-05-07 21:32","pubTimestamp":1746624755,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryCognition Therapeutics Inc CGTX.OQ reported a quarterly adjusted loss of 14 cents per share for the quarter ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL8N3RF1Y4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX"],"gpt_icon":0},{"id":"2533989550","title":"Press Release: Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2533989550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533989550?lang=en_us&edition=fundamental","pubTime":"2025-05-07 19:30","pubTimestamp":1746617400,"startTime":"0","endTime":"0","summary":"- End-of-Phase 2 meeting with FDA requested for Alzheimer's disease -. - Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC -. - Two posters at ARVO describe zervimesine's role supporting retinal cell health -. PURCHASE, N.Y., May 07, 2025  -- Cognition Therapeutics, Inc.  , a clinical-stage company developing drugs that treat neurodegenerative disorders, today reported financial results for the first quarter ended March 31, 2025, and provided a business update.\"During our first quarter of 2025 and in recent weeks, we continued to advance our Alzheimer's disease and dementia with Lewy bodies  programs,\" stated Lisa Ricciardi, Cognition's president and CEO. \"A request was made with the U.S. Food and Drug Administration to schedule an end-of-Phase 2  meeting to review the results from the SHINE study in Alzheimer's disease and discuss plans for a registrational study. In order to request separate EOP2 meetings for each indication, both need to have a uniq","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240878834.USD","LU0205194284.USD","LU0345774391.USD","LENZ","LU0345774631.USD","BK4007","BK4139","LU0240877869.USD","BK4097","LU0348723411.USD","BK4110","CGTX","AAIC","LU0205193047.USD","DLB"],"gpt_icon":0},{"id":"2532484422","title":"Cognition Therapeutics Inc  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2532484422","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532484422?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:49","pubTimestamp":1746193761,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics Inc  expected to post a loss of11cents a share - Earnings Preview Cognition Therapeutics Inc CGTX.OQ CGTX.O is expected to show no change in quarterly revenue when it reports  r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL8N3RA24U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"CGTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-03-20","symbol":"CGTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2024-11-13","symbol":"CGTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2024-08-08","symbol":"CGTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2024-05-07","symbol":"CGTX","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1738123200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGTX","date":"2025-08-01","current":-1.090556,"percent":0.741971,"low":-56.313627,"twenty":-3.566507,"median":-2.325501,"eighty":-0.806706,"high":-0.444935,"avg":-5.372795,"sd":10.349625,"marketCap":36315526},"quantilePoints":[{"date":"2021-10-08","current":-54.318634,"twenty":-53.008521,"median":-51.043352,"eighty":-51.043352,"marketCap":267573589},{"date":"2021-10-15","current":-51.628056,"twenty":-52.877541,"median":-52.429288,"eighty":-51.277234,"marketCap":254319802},{"date":"2021-10-22","current":-52.061905,"twenty":-52.877541,"median":-52.319436,"eighty":-51.801596,"marketCap":256456944},{"date":"2021-10-29","current":-52.452369,"twenty":-52.782095,"median":-52.474061,"eighty":-52.061905,"marketCap":258380371},{"date":"2021-11-05","current":-52.148675,"twenty":-52.955634,"median":-52.495754,"eighty":-52.061905,"marketCap":256884372},{"date":"2021-11-12","current":-50.933897,"twenty":-52.999019,"median":-52.582524,"eighty":-52.061905,"marketCap":250900376},{"date":"2021-11-19","current":-36.38032,"twenty":-52.955634,"median":-52.495754,"eighty":-51.043352,"marketCap":227195098},{"date":"2021-11-26","current":-31.475505,"twenty":-52.903572,"median":-52.365599,"eighty":-46.578051,"marketCap":196564527},{"date":"2021-12-03","current":-29.323032,"twenty":-52.790772,"median":-52.10529,"eighty":-35.646362,"marketCap":183122334},{"date":"2021-12-10","current":-28.405584,"twenty":-52.756064,"median":-52.061905,"eighty":-31.172041,"marketCap":177392875},{"date":"2021-12-17","current":-18.525381,"twenty":-52.747387,"median":-51.043352,"eighty":-29.591209,"marketCap":115691005},{"date":"2021-12-23","current":-21.736447,"twenty":-52.712679,"median":-50.456663,"eighty":-29.181886,"marketCap":135744113},{"date":"2021-12-31","current":-22.30103,"twenty":-52.625909,"median":-38.074069,"eighty":-22.30103,"marketCap":139269934},{"date":"2022-01-07","current":-20.289703,"twenty":-52.625909,"median":-35.921596,"eighty":-22.054025,"marketCap":126709196},{"date":"2022-01-14","current":-22.054025,"twenty":-52.539139,"median":-31.475505,"eighty":-22.054025,"marketCap":137727387},{"date":"2022-01-21","current":-12.350254,"twenty":-52.504431,"median":-31.12264,"eighty":-21.708218,"marketCap":77127337},{"date":"2022-01-28","current":-12.244395,"twenty":-52.495754,"median":-29.975831,"eighty":-21.073062,"marketCap":76466245},{"date":"2022-02-04","current":-15.56132,"twenty":-52.461046,"median":-29.323032,"eighty":-20.106214,"marketCap":97180444},{"date":"2022-02-11","current":-14.149862,"twenty":-52.382953,"median":-28.793735,"eighty":-17.974913,"marketCap":88365891},{"date":"2022-02-18","current":-11.609239,"twenty":-52.328669,"median":-25.018086,"eighty":-15.554263,"marketCap":72499696},{"date":"2022-02-25","current":-10.233068,"twenty":-52.216979,"median":-24.312357,"eighty":-14.904992,"marketCap":63905507},{"date":"2022-03-04","current":-8.856896,"twenty":-52.096613,"median":-22.35396,"eighty":-14.432154,"marketCap":55311318},{"date":"2022-03-11","current":-9.492052,"twenty":-52.061905,"median":-22.054025,"eighty":-12.98541,"marketCap":59277867},{"date":"2022-03-18","current":-10.550646,"twenty":-52.061905,"median":-22.054025,"eighty":-12.597259,"marketCap":65888782},{"date":"2022-03-25","current":-10.515359,"twenty":-51.801596,"median":-21.736447,"eighty":-11.524551,"marketCap":65668418},{"date":"2022-04-01","current":-5.010611,"twenty":-51.277234,"median":-21.20715,"eighty":-10.74825,"marketCap":58704318},{"date":"2022-04-08","current":-6.032005,"twenty":-51.043352,"median":-20.677854,"eighty":-10.451844,"marketCap":70670967},{"date":"2022-04-14","current":-5.588758,"twenty":-50.99957,"median":-20.32499,"eighty":-10.275412,"marketCap":65477893},{"date":"2022-04-22","current":-6.070548,"twenty":-50.55211,"median":-19.33697,"eighty":-9.449708,"marketCap":71122539},{"date":"2022-04-29","current":-5.342796,"twenty":-48.27874,"median":-17.996085,"eighty":-9.287391,"marketCap":62596202},{"date":"2022-05-06","current":-5.786422,"twenty":-42.666251,"median":-15.878898,"eighty":-8.856896,"marketCap":67793721},{"date":"2022-05-13","current":-4.18241,"twenty":-37.961153,"median":-15.526034,"eighty":-6.50994,"marketCap":65985888},{"date":"2022-05-20","current":-3.938914,"twenty":-37.227195,"median":-14.855591,"eighty":-6.062092,"marketCap":62144244},{"date":"2022-05-27","current":-3.838651,"twenty":-36.013341,"median":-14.538013,"eighty":-5.911684,"marketCap":60562390},{"date":"2022-06-03","current":-3.566507,"twenty":-35.13118,"median":-14.326295,"eighty":-5.79028,"marketCap":56268788},{"date":"2022-06-10","current":-2.750078,"twenty":-33.338629,"median":-13.214772,"eighty":-5.589715,"marketCap":43387981},{"date":"2022-06-17","current":-2.377672,"twenty":-31.454333,"median":-12.844264,"eighty":-5.461433,"marketCap":37512525},{"date":"2022-06-24","current":-2.635491,"twenty":-31.369645,"median":-12.667832,"eighty":-5.323508,"marketCap":41580148},{"date":"2022-07-01","current":-3.222748,"twenty":-31.12264,"median":-12.297325,"eighty":-5.12624,"marketCap":50845290},{"date":"2022-07-08","current":-3.365981,"twenty":-30.727432,"median":-11.50338,"eighty":-4.150899,"marketCap":53105081},{"date":"2022-07-15","current":-2.878988,"twenty":-30.233422,"median":-10.832937,"eighty":-3.861568,"marketCap":45421793},{"date":"2022-07-22","current":-3.036544,"twenty":-29.880558,"median":-10.638862,"eighty":-3.746982,"marketCap":47907562},{"date":"2022-07-29","current":-2.707108,"twenty":-29.591209,"median":-10.480073,"eighty":-3.577966,"marketCap":42710044},{"date":"2022-08-05","current":-4.4832,"twenty":-29.365376,"median":-10.374213,"eighty":-3.555048,"marketCap":70731448},{"date":"2022-08-12","current":-2.561319,"twenty":-29.266574,"median":-10.162495,"eighty":-3.489161,"marketCap":51326263},{"date":"2022-08-19","current":-2.334653,"twenty":-29.196001,"median":-9.456765,"eighty":-3.268697,"marketCap":46784116},{"date":"2022-08-26","current":-2.334653,"twenty":-28.560844,"median":-9.350907,"eighty":-3.151131,"marketCap":46784116},{"date":"2022-09-02","current":-2.130654,"twenty":-27.812772,"median":-9.20976,"eighty":-3.036544,"marketCap":42696183},{"date":"2022-09-09","current":-2.096655,"twenty":-26.076679,"median":-8.892183,"eighty":-2.98689,"marketCap":42014861},{"date":"2022-09-16","current":-1.983322,"twenty":-24.615821,"median":-8.751037,"eighty":-2.936281,"marketCap":39743788},{"date":"2022-09-23","current":-1.892656,"twenty":-24.326472,"median":-6.533066,"eighty":-2.878988,"marketCap":37926929},{"date":"2022-09-30","current":-2.153321,"twenty":-23.423139,"median":-6.128363,"eighty":-2.844612,"marketCap":43150398},{"date":"2022-10-07","current":-2.187321,"twenty":-22.576265,"median":-6.04423,"eighty":-2.724296,"marketCap":43831720},{"date":"2022-10-14","current":-2.062655,"twenty":-22.343374,"median":-5.954918,"eighty":-2.618303,"marketCap":41333539},{"date":"2022-10-21","current":-1.937989,"twenty":-22.173999,"median":-5.832135,"eighty":-2.511452,"marketCap":38835358},{"date":"2022-10-28","current":-2.209987,"twenty":-22.06814,"median":-5.762203,"eighty":-2.37906,"marketCap":44285935},{"date":"2022-11-04","current":-2.028655,"twenty":-22.054025,"median":-5.59115,"eighty":-2.341453,"marketCap":40652217},{"date":"2022-11-11","current":-1.908266,"twenty":-22.054025,"median":-5.554965,"eighty":-2.293854,"marketCap":38239736},{"date":"2022-11-18","current":-1.80798,"twenty":-22.054025,"median":-5.41764,"eighty":-2.243987,"marketCap":42585160},{"date":"2022-11-25","current":-3.050198,"twenty":-21.969337,"median":-5.333152,"eighty":-2.243987,"marketCap":71844352},{"date":"2022-12-02","current":-3.456071,"twenty":-21.799962,"median":-5.222598,"eighty":-2.243987,"marketCap":81404286},{"date":"2022-12-09","current":-2.819045,"twenty":-21.679989,"median":-5.141318,"eighty":-2.251626,"marketCap":66399786},{"date":"2022-12-16","current":-2.737629,"twenty":-21.454155,"median":-4.4832,"eighty":-2.264513,"marketCap":64482102},{"date":"2022-12-23","current":-2.904609,"twenty":-21.214208,"median":-4.168087,"eighty":-2.264513,"marketCap":68415151},{"date":"2022-12-30","current":-2.584609,"twenty":-21.171864,"median":-4.117955,"eighty":-2.266654,"marketCap":60877889},{"date":"2023-01-06","current":-2.781532,"twenty":-21.171864,"median":-3.953237,"eighty":-2.266654,"marketCap":65516204},{"date":"2023-01-13","current":-2.732301,"twenty":-20.677854,"median":-3.838651,"eighty":-2.289838,"marketCap":64356625},{"date":"2023-01-20","current":-2.498456,"twenty":-20.508479,"median":-3.795681,"eighty":-2.307557,"marketCap":58848626},{"date":"2023-01-27","current":-2.486148,"twenty":-20.353219,"median":-3.716902,"eighty":-2.321053,"marketCap":58558731},{"date":"2023-02-03","current":-2.609225,"twenty":-20.29676,"median":-3.580831,"eighty":-2.332386,"marketCap":61457678},{"date":"2023-02-10","current":-2.289225,"twenty":-19.555745,"median":-3.53786,"eighty":-2.332386,"marketCap":53920416},{"date":"2023-02-17","current":-2.215379,"twenty":-19.315798,"median":-3.509214,"eighty":-2.289715,"marketCap":52181047},{"date":"2023-02-24","current":-1.864611,"twenty":-18.835902,"median":-3.408951,"eighty":-2.266654,"marketCap":43919048},{"date":"2023-03-03","current":-2.079995,"twenty":-18.207803,"median":-3.294436,"eighty":-2.243987,"marketCap":48992205},{"date":"2023-03-10","current":-2.087168,"twenty":-17.932569,"median":-3.197788,"eighty":-2.24239,"marketCap":49161146},{"date":"2023-03-17","current":-2.211404,"twenty":-16.725773,"median":-3.151131,"eighty":-2.225141,"marketCap":52087404},{"date":"2023-03-24","current":-2.653148,"twenty":-15.864783,"median":-3.136292,"eighty":-2.218944,"marketCap":56769418},{"date":"2023-03-31","current":-2.707853,"twenty":-15.660122,"median":-3.098992,"eighty":-2.225141,"marketCap":57939922},{"date":"2023-04-06","current":-2.502712,"twenty":-15.547206,"median":-3.050198,"eighty":-2.229674,"marketCap":53550534},{"date":"2023-04-14","current":-2.448008,"twenty":-15.427232,"median":-3.036544,"eighty":-2.23559,"marketCap":52380030},{"date":"2023-04-21","current":-2.297572,"twenty":-15.208456,"median":-2.985617,"eighty":-2.241592,"marketCap":49161146},{"date":"2023-04-28","current":-2.33977,"twenty":-14.904992,"median":-2.950605,"eighty":-2.243987,"marketCap":50064065},{"date":"2023-05-05","current":-2.285039,"twenty":-14.608586,"median":-2.920445,"eighty":-2.241592,"marketCap":48892975},{"date":"2023-05-12","current":-1.960622,"twenty":-14.580357,"median":-2.893311,"eighty":-2.217756,"marketCap":46527513},{"date":"2023-05-19","current":-2.467425,"twenty":-14.523899,"median":-2.871827,"eighty":-2.205838,"marketCap":58554454},{"date":"2023-05-26","current":-2.430413,"twenty":-14.432154,"median":-2.858289,"eighty":-2.210554,"marketCap":57676137},{"date":"2023-06-02","current":-3.071944,"twenty":-14.291008,"median":-2.850341,"eighty":-2.212199,"marketCap":72900295},{"date":"2023-06-09","current":-3.701137,"twenty":-13.994602,"median":-2.864665,"eighty":-2.216567,"marketCap":87831681},{"date":"2023-06-16","current":-3.6888,"twenty":-13.310045,"median":-2.878988,"eighty":-2.222594,"marketCap":87538908},{"date":"2023-06-23","current":-3.269338,"twenty":-13.055983,"median":-2.893311,"eighty":-2.227687,"marketCap":77584651},{"date":"2023-06-30","current":-2.158997,"twenty":-12.914837,"median":-2.893311,"eighty":-2.226414,"marketCap":51235147},{"date":"2023-07-07","current":-1.961603,"twenty":-12.858379,"median":-2.878988,"eighty":-2.210837,"marketCap":46550790},{"date":"2023-07-14","current":-2.220682,"twenty":-12.759576,"median":-2.864665,"eighty":-2.20302,"marketCap":52699008},{"date":"2023-07-21","current":-2.134322,"twenty":-12.681946,"median":-2.850341,"eighty":-2.185861,"marketCap":50649602},{"date":"2023-07-28","current":-2.072637,"twenty":-12.561973,"median":-2.826229,"eighty":-2.183671,"marketCap":49185741},{"date":"2023-08-04","current":-2.183671,"twenty":-12.406712,"median":-2.808868,"eighty":-2.180597,"marketCap":51820691},{"date":"2023-08-11","current":-2.24283,"twenty":-12.286739,"median":-2.785721,"eighty":-2.183671,"marketCap":50923457},{"date":"2023-08-18","current":-2.029227,"twenty":-11.863301,"median":-2.744609,"eighty":-2.168944,"marketCap":46073604},{"date":"2023-08-25","current":-2.029227,"twenty":-11.482208,"median":-2.736692,"eighty":-2.147762,"marketCap":46073604},{"date":"2023-09-01","current":-2.069278,"twenty":-11.334005,"median":-2.721529,"eighty":-2.134322,"marketCap":46982952},{"date":"2023-09-07","current":-2.029227,"twenty":-11.291661,"median":-2.717274,"eighty":-2.134322,"marketCap":46073604},{"date":"2023-09-13","current":-1.922426,"twenty":-11.016427,"median":-2.715721,"eighty":-2.130654,"marketCap":43648678},{"date":"2023-09-22","current":-1.708823,"twenty":-10.804708,"median":-2.707853,"eighty":-2.110595,"marketCap":38798824},{"date":"2023-09-28","current":-1.788924,"twenty":-10.755307,"median":-2.702213,"eighty":-2.099254,"marketCap":40617519},{"date":"2023-10-05","current":-1.828975,"twenty":-10.727078,"median":-2.692436,"eighty":-2.087168,"marketCap":41526867},{"date":"2023-10-11","current":-1.802274,"twenty":-10.621219,"median":-2.686743,"eighty":-2.085321,"marketCap":40920635},{"date":"2023-10-20","current":-1.695473,"twenty":-10.543589,"median":-2.684528,"eighty":-2.080991,"marketCap":38495709},{"date":"2023-10-27","current":-1.49522,"twenty":-10.536531,"median":-2.683071,"eighty":-2.079135,"marketCap":33948971},{"date":"2023-11-03","current":-1.361718,"twenty":-10.508302,"median":-2.666389,"eighty":-2.072637,"marketCap":30917813},{"date":"2023-11-10","current":-1.332388,"twenty":-10.480073,"median":-2.653148,"eighty":-2.069278,"marketCap":30417082},{"date":"2023-11-17","current":-1.332388,"twenty":-10.423615,"median":-2.646148,"eighty":-2.06131,"marketCap":30417082},{"date":"2023-11-24","current":-1.345712,"twenty":-10.4095,"median":-2.628512,"eighty":-2.052945,"marketCap":30721252},{"date":"2023-11-30","current":-1.425655,"twenty":-10.395385,"median":-2.607276,"eighty":-2.048349,"marketCap":32546277},{"date":"2023-12-07","current":-1.812047,"twenty":-10.353042,"median":-2.598444,"eighty":-2.042577,"marketCap":41367231},{"date":"2023-12-14","current":-2.345003,"twenty":-10.338927,"median":-2.595483,"eighty":-2.042577,"marketCap":53534064},{"date":"2024-01-05","current":-2.771916,"twenty":-10.275412,"median":-2.592521,"eighty":-2.045808,"marketCap":63280072},{"date":"2024-01-12","current":-2.842269,"twenty":-10.190724,"median":-2.607276,"eighty":-2.047962,"marketCap":64886165},{"date":"2024-01-19","current":-3.236247,"twenty":-10.035464,"median":-2.628512,"eighty":-2.048736,"marketCap":73880287},{"date":"2024-01-26","current":-3.194035,"twenty":-9.703771,"median":-2.653148,"eighty":-2.050467,"marketCap":72916631},{"date":"2024-02-02","current":-3.222177,"twenty":-9.463823,"median":-2.665604,"eighty":-2.051322,"marketCap":73559068},{"date":"2024-02-09","current":-3.165894,"twenty":-9.39325,"median":-2.683071,"eighty":-2.052945,"marketCap":72274194},{"date":"2024-02-16","current":-2.785987,"twenty":-9.350907,"median":-2.688118,"eighty":-2.055599,"marketCap":63601290},{"date":"2024-02-23","current":-2.828199,"twenty":-9.350907,"median":-2.696348,"eighty":-2.057273,"marketCap":64564946},{"date":"2024-03-01","current":-2.912622,"twenty":-9.329735,"median":-2.707853,"eighty":-2.062655,"marketCap":66492258},{"date":"2024-03-08","current":-2.771916,"twenty":-9.230932,"median":-2.7149,"eighty":-2.06398,"marketCap":63280072},{"date":"2024-03-15","current":-2.5285,"twenty":-9.125073,"median":-2.714167,"eighty":-2.069278,"marketCap":57723128},{"date":"2024-03-22","current":-2.684756,"twenty":-8.913354,"median":-2.707853,"eighty":-2.069278,"marketCap":61290288},{"date":"2024-03-28","current":-2.288672,"twenty":-8.856896,"median":-2.702213,"eighty":-2.069278,"marketCap":59020277},{"date":"2024-04-05","current":-2.918811,"twenty":-8.856896,"median":-2.707853,"eighty":-2.072637,"marketCap":75270293},{"date":"2024-04-12","current":-3.160785,"twenty":-8.751037,"median":-2.716454,"eighty":-2.072637,"marketCap":81510317},{"date":"2024-04-19","current":-2.7827,"twenty":-8.504032,"median":-2.721529,"eighty":-2.072637,"marketCap":71760279},{"date":"2024-04-26","current":-2.918811,"twenty":-6.648695,"median":-2.734028,"eighty":-2.073988,"marketCap":75270293},{"date":"2024-05-03","current":-3.074207,"twenty":-6.417436,"median":-2.737629,"eighty":-2.078562,"marketCap":79277655},{"date":"2024-05-10","current":-2.658425,"twenty":-6.321078,"median":-2.741119,"eighty":-2.079995,"marketCap":76474910},{"date":"2024-05-17","current":-2.70148,"twenty":-6.128363,"median":-2.73733,"eighty":-2.084974,"marketCap":77713486},{"date":"2024-05-24","current":-3.620541,"twenty":-6.070548,"median":-2.741119,"eighty":-2.085321,"marketCap":104152094},{"date":"2024-05-31","current":-2.743256,"twenty":-6.059274,"median":-2.744609,"eighty":-2.085321,"marketCap":78915241},{"date":"2024-06-07","current":-2.548304,"twenty":-6.036895,"median":-2.743256,"eighty":-2.085321,"marketCap":73307051},{"date":"2024-06-14","current":-3.063534,"twenty":-5.997316,"median":-2.744609,"eighty":-2.086429,"marketCap":88128695},{"date":"2024-06-21","current":-2.840732,"twenty":-5.966481,"median":-2.750078,"eighty":-2.089222,"marketCap":81719335},{"date":"2024-06-28","current":-2.325501,"twenty":-5.958772,"median":-2.750078,"eighty":-2.091276,"marketCap":66897691},{"date":"2024-07-05","current":-2.464753,"twenty":-5.911684,"median":-2.744609,"eighty":-2.094508,"marketCap":70903541},{"date":"2024-07-12","current":-2.548304,"twenty":-5.868281,"median":-2.740443,"eighty":-2.096384,"marketCap":73307051},{"date":"2024-07-15","current":-2.757181,"twenty":-5.863421,"median":-2.743256,"eighty":-2.09652,"marketCap":79315826},{"date":"2024-08-02","current":-1.253264,"twenty":-5.858561,"median":-2.740443,"eighty":-2.095978,"marketCap":36052648},{"date":"2024-08-09","current":-0.753562,"twenty":-5.80571,"median":-2.735755,"eighty":-2.085321,"marketCap":23422203},{"date":"2024-08-16","current":-0.828948,"twenty":-5.786422,"median":-2.729518,"eighty":-2.078562,"marketCap":25765360},{"date":"2024-08-23","current":-0.979372,"twenty":-5.762203,"median":-2.717274,"eighty":-2.072637,"marketCap":30440850},{"date":"2024-08-30","current":-0.916749,"twenty":-5.593541,"median":-2.71552,"eighty":-2.062655,"marketCap":28494402},{"date":"2024-09-06","current":-0.785693,"twenty":-5.593541,"median":-2.714787,"eighty":-2.054568,"marketCap":24420906},{"date":"2024-09-13","current":-0.779366,"twenty":-5.589715,"median":-2.714099,"eighty":-2.047962,"marketCap":24224255},{"date":"2024-09-20","current":-0.786855,"twenty":-5.577154,"median":-2.70748,"eighty":-2.041187,"marketCap":24457026},{"date":"2024-09-27","current":-0.52939,"twenty":-5.558823,"median":-2.70018,"eighty":-2.029227,"marketCap":16454514},{"date":"2024-10-04","current":-0.561541,"twenty":-5.551165,"median":-2.692436,"eighty":-2.027934,"marketCap":17453824},{"date":"2024-10-11","current":-0.528099,"twenty":-5.461433,"median":-2.685985,"eighty":-2.017322,"marketCap":16414381},{"date":"2024-10-18","current":-0.575357,"twenty":-5.404682,"median":-2.680114,"eighty":-1.999884,"marketCap":17883247},{"date":"2024-10-25","current":-0.761677,"twenty":-5.353445,"median":-2.666389,"eighty":-1.984892,"marketCap":23674433},{"date":"2024-10-31","current":-0.685625,"twenty":-5.331223,"median":-2.659705,"eighty":-1.983322,"marketCap":21310602},{"date":"2024-11-08","current":-0.67168,"twenty":-5.309214,"median":-2.653148,"eighty":-1.978496,"marketCap":20877166},{"date":"2024-11-15","current":-0.599125,"twenty":-5.253433,"median":-2.64578,"eighty":-1.966526,"marketCap":20532022},{"date":"2024-11-22","current":-0.515042,"twenty":-5.213707,"median":-2.633673,"eighty":-1.956102,"marketCap":17650476},{"date":"2024-11-29","current":-0.487374,"twenty":-5.187226,"median":-2.619731,"eighty":-1.937989,"marketCap":16702293},{"date":"2024-12-06","current":-0.458398,"twenty":-5.144334,"median":-2.609225,"eighty":-1.922426,"marketCap":15709296},{"date":"2024-12-13","current":-0.616612,"twenty":-5.079988,"median":-2.598985,"eighty":-1.90713,"marketCap":21131310},{"date":"2024-12-20","current":-0.768644,"twenty":-4.799647,"median":-2.592521,"eighty":-1.866762,"marketCap":26341428},{"date":"2024-12-27","current":-0.930374,"twenty":-4.449963,"median":-2.590079,"eighty":-1.848993,"marketCap":31883931},{"date":"2025-01-03","current":-0.876666,"twenty":-4.317013,"median":-2.584832,"eighty":-1.825371,"marketCap":30043355},{"date":"2025-01-10","current":-0.953652,"twenty":-4.209331,"median":-2.584609,"eighty":-1.806839,"marketCap":32681652},{"date":"2025-01-17","current":-0.84175,"twenty":-4.17244,"median":-2.560657,"eighty":-1.775574,"marketCap":28846772},{"date":"2025-01-24","current":-0.953046,"twenty":-4.160238,"median":-2.557163,"eighty":-1.730183,"marketCap":32660878},{"date":"2025-01-31","current":-0.931466,"twenty":-4.14517,"median":-2.548304,"eighty":-1.695473,"marketCap":31921324},{"date":"2025-02-07","current":-0.775797,"twenty":-4.113658,"median":-2.535095,"eighty":-1.682123,"marketCap":26586562},{"date":"2025-02-14","current":-0.7153,"twenty":-4.019124,"median":-2.52911,"eighty":-1.620963,"marketCap":24513317},{"date":"2025-02-21","current":-0.739062,"twenty":-3.959688,"median":-2.5285,"eighty":-1.507172,"marketCap":25327657},{"date":"2025-02-28","current":-0.55563,"twenty":-3.944293,"median":-2.516839,"eighty":-1.437461,"marketCap":19041446},{"date":"2025-03-07","current":-0.522896,"twenty":-3.910267,"median":-2.502712,"eighty":-1.402377,"marketCap":17919650},{"date":"2025-03-14","current":-0.503134,"twenty":-3.855839,"median":-2.492302,"eighty":-1.377689,"marketCap":17242417},{"date":"2025-03-21","current":-0.521872,"twenty":-3.827192,"median":-2.467425,"eighty":-1.352114,"marketCap":17728529},{"date":"2025-03-28","current":-0.822207,"twenty":-3.804275,"median":-2.463143,"eighty":-1.332388,"marketCap":27931206},{"date":"2025-04-04","current":-0.704176,"twenty":-3.778493,"median":-2.449225,"eighty":-1.016109,"marketCap":23921557},{"date":"2025-04-11","current":-0.582678,"twenty":-3.741252,"median":-2.44554,"eighty":-0.978985,"marketCap":19794158},{"date":"2025-04-17","current":-0.680825,"twenty":-3.721199,"median":-2.436234,"eighty":-0.953167,"marketCap":23128303},{"date":"2025-04-25","current":-0.805241,"twenty":-3.70802,"median":-2.434332,"eighty":-0.930592,"marketCap":27354858},{"date":"2025-05-02","current":-0.815822,"twenty":-3.69867,"median":-2.424964,"eighty":-0.918859,"marketCap":27714301},{"date":"2025-05-09","current":-0.614146,"twenty":-3.681398,"median":-2.421867,"eighty":-0.914274,"marketCap":20451072},{"date":"2025-05-16","current":-0.586607,"twenty":-3.651109,"median":-2.389648,"eighty":-0.902546,"marketCap":19534008},{"date":"2025-05-23","current":-0.586421,"twenty":-3.644136,"median":-2.387687,"eighty":-0.894261,"marketCap":19527809},{"date":"2025-05-30","current":-0.462807,"twenty":-3.627114,"median":-2.379986,"eighty":-0.876545,"marketCap":15411471},{"date":"2025-06-06","current":-0.540066,"twenty":-3.627114,"median":-2.376526,"eighty":-0.850237,"marketCap":17984182},{"date":"2025-06-13","current":-0.573389,"twenty":-3.620541,"median":-2.371254,"eighty":-0.828948,"marketCap":19093858},{"date":"2025-06-20","current":-0.521263,"twenty":-3.61593,"median":-2.363071,"eighty":-0.818059,"marketCap":17358052},{"date":"2025-06-27","current":-0.604106,"twenty":-3.614777,"median":-2.352864,"eighty":-0.807073,"marketCap":20116743},{"date":"2025-07-03","current":-0.755273,"twenty":-3.594409,"median":-2.349894,"eighty":-0.79902,"marketCap":25150578},{"date":"2025-07-11","current":-1.302599,"twenty":-3.580831,"median":-2.345003,"eighty":-0.79902,"marketCap":43376534},{"date":"2025-07-18","current":-1.265924,"twenty":-3.578992,"median":-2.339253,"eighty":-0.802845,"marketCap":42155271},{"date":"2025-07-25","current":-1.604,"twenty":-3.571011,"median":-2.334653,"eighty":-0.80546,"marketCap":53413208},{"date":"2025-08-01","current":-1.090556,"twenty":-3.566507,"median":-2.325501,"eighty":-0.806706,"marketCap":36315526}],"updateTime":1754148320580}}}